Form D — Belhaven Biopharma Inc.
0001231919-25-000318 · filed Oct 15, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $32,289,627
- Reported amount sold
- $32,289,627
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Belhaven Biopharma Inc.
- CIK
- 1873965
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 84406 Winslow
Chapel Hill, North Carolina 27517 - Phone
- 919-656-8658
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Scott David Lyman · Executive OfficerChapel Hill, North Carolina Find on LinkedIn ↗
-
David Algon Neal · Executive OfficerChapel Hill, North Carolina Find on LinkedIn ↗
-
Wes Wheeler · DirectorChapel Hill, North Carolina Find on LinkedIn ↗
-
Derek Winstanly · DirectorChapel Hill, North Carolina Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗